RNA Sequencing: Technologies and Global Markets

Report Code: BIO147B

Publish Date: Sep 2024

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2024 to 2029.

Report Includes

  • 65 data tables and 57 additional tables
  • A review of the global market and technologies for RNA sequencing
  • Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the overall market for RNA sequencing, and corresponding market share analysis by product, technology, application, end-user and region
  • Discussion of recent RNA sequencing approaches such as next-generation sequencing (NGS) technology, single nucleotide polymorphism (SNP) discovery, RNA editing, and Sanger sequencing technology
  • Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
  • Analysis of the regulatory landscape and macroeconomic factors impacting the market
  • Coverage of the most recent approvals, recalls, safety alerts and clinical trials
  • Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes
  • Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding
  • Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., and Qiagen

Report Scope

This research report covers the global market for RNA sequencing. It incorporates an in-depth analysis of the RNA sequencing market, including market estimates and trends through 2029. For this analysis, the market has been segmented based on products, technologies, applications, end users and regions. In terms of geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for the base year 2023, with forecasts for 2024 through 2029.

This report also examines strategies and collaborations, discusses the regulatory landscape and analyzes macroeconomic factors when considering new technologies, the industry’s growing competition and changing customer needs. It also includes various analytical frameworks, such as ESG analysis, competitive analysis and strategic recommendations, that will help companies operating within this market devise their strategic plan of action.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $3.7 billion
Market size forecast $10.3 billion
Growth rate CAGR of 19.1% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered Technologies, Products, Applications, End Users and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Rapid advances in data analysis capabilities.
  • Favorable funding scenario for genomics and biomedical research activities.
  • A decline in the prices of genome sequencing.
  • Growing prevalence of cancer generating demand for personalized treatments.
  • Blockchain and cloud computing technologies
Companies studied
10X GENOMICSAGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)BIO-RAD LABORATORIES INC.
BGIF. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.INTEGRATED DNA TECHNOLOGIES INC.
MICROSYNTH AGOXFORD NANOPORE TECHNOLOGIES PLC.
QIAGENREVVITY
STANDARD BIOTOOLSTHERMO FISHER SCIENTIFIC INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global RNA sequencing market is valued at an estimated $4.3 billion in 2024. It is projected to reach $10.3 billion by 2029, at an estimated CAGR of 19.1% from 2024 to 2029.
  • Rapid advances in data analysis capabilities
  • Favorable funding scenario for genomics and biomedical research activities
  • Decline in the prices of genome sequencing methods.
  • Growing prevalence of cancer generating demand for personalized treatments.
The report will provide information on the RNA sequencing market and their growth projections in the coming years. Recent developments of companies operating in this market space have been covered. Information about products, technologies, applications, ESG analysis, competitive analysis, and business strategies have been provided in the report. The report also identifies promising and emerging countries where the established players can plausibly expand their business.
The sequencing-by-synthesis segment dominates the RNA sequencing market and will continue to do so by 2029.
North America holds the highest share of the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: RNA Sequencing: Technologies and Global Markets166Free
Chapter- 1: Executive Summary6Free
Chapter- 2: Market Overview 14Free
Chapter- 3: Market Dynamics 7Free
Chapter- 4: Emerging Technologies and Developments 2Free
Chapter- 5: Market Segmentation Analysis70Free
Chapter- 6: Competitive Intelligence12Free
Chapter- 7: Sustainability in RNA Sequencing Market: ESG Perspective 9Free
Chapter- 8: Appendix46Free
Published - Mar-2016| Analyst - Faqing Yuan| Code - BIO147A

Report Highlights

The global RNA-Sequencing market should reach nearly $2.1 billion in 2020, from over $1.0 billion in 2015 registering a compound annual growth rate (CAGR) of 14.9%.

Report Includes

  • An overview of the global markets for RNA sequencing and related technologies.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2020.
  • Analysis of RNA sequencing clinical application initiatives.
  • Evaluation of collaboration and merger and acquisition activity.
  • A look at the regulatory environment and its effect on the market.
  • Analyses of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Identification of patents with the potential to make an impact in the RNA sequencing industry.
  • Profiles of major players in the industry.

Related Reports

Global DNA Sequencing: Research, Applied and Clinical Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - BIO045J

The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.

Synthetic Biology: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO066H

The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - BIO126E

The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.

Global Next-Generation Sequencing on Drug Development Market

Published - Sep 2023 | Publisher - BCC Publishing | Code - BIO246A

The global next-generation sequencing (NGS) market in drug development should reach $2.9 billion by 2028 from $1.3 billion in 2023 at a compound annual growth rate (CAGR) of 17.7% for the forecast period of 2023 to 2028.

Recent Reports

Global DNA Sequencing: Research, Applied and Clinical Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - BIO045J

The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.

Artificial Intelligence (AI) in Cancer

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO196B

The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Induced Pluripotent Stem Cells: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO135F

The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
RNA Sequencing: Technologies and Global Markets
Sample Report